The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Crowe, James Scott
    Research & Development born in January 1958
    Individual (1 offspring)
    Officer
    2008-06-11 ~ now
    OF - Director → CIF 0
    Mr James Scott Crowe
    Born in January 1958
    Individual (1 offspring)
    Person with significant control
    2024-11-29 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Crowe, Jonathan
    Consultant born in May 1987
    Individual (1 offspring)
    Officer
    2008-06-11 ~ now
    OF - Director → CIF 0
  • 3
    Manster, Pamela Kathleen
    Individual (78 offsprings)
    Officer
    2008-06-11 ~ now
    OF - Secretary → CIF 0
Ceased 2
  • 1
    Crowe, Anne Elizabeth
    Administration Director born in May 1954
    Individual
    Officer
    2008-06-11 ~ 2024-11-29
    OF - Director → CIF 0
    Mrs Anne Elizabeth Crowe
    Born in May 1954
    Individual
    Person with significant control
    2016-06-12 ~ 2024-11-29
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Mr James Scott Crowe
    Born in January 1958
    Individual (1 offspring)
    Person with significant control
    2016-06-12 ~ 2023-03-31
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

IMMUNOPHARMA CONSULTING LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Cash at bank and in hand
110,933 GBP2023-08-31
97,204 GBP2022-08-31
Creditors
Current
32,207 GBP2023-08-31
28,066 GBP2022-08-31
Net Current Assets/Liabilities
78,726 GBP2023-08-31
Total Assets Less Current Liabilities
78,726 GBP2023-08-31
69,138 GBP2022-08-31
Equity
Called up share capital
100 GBP2023-08-31
100 GBP2022-08-31
Equity
78,726 GBP2023-08-31
69,138 GBP2022-08-31
Number of shares allotted
Class 1 ordinary share
100 shares2022-09-01 ~ 2023-08-31
Par Value of Share
Class 1 ordinary share
1 GBP2022-09-01 ~ 2023-08-31

  • IMMUNOPHARMA CONSULTING LTD
    Info
    Registered number 06617668
    20 Westlands Way, Oxted, Surrey RH8 0ND
    Private Limited Company incorporated on 2008-06-11 (17 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-11-29
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.